Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-30 · accession 0001140361-23-000545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-04 | 2022-12-30+ | ROIV | Venker Eric | Pres, COO | S - Sale | $7.46 | -119.2K | 753.5K | -14% | -$889.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-12-30 | S | D | 23,761 | $8.00 | 848,950 | D | — | — | (F2) A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings. |
| 2 | Common | Common Shares | 2023-01-03 | S | D | 95,484 | $7.32 | 753,466 | D | — | — | (F2) A Form 4 filed by the reporting person on December 28, 2022 inadvertently overstated the total number of Common Shares held by the reporting person by 28,936 Common Shares. The updated amounts reported here correct that error and reflect the reporting person's holdings. |